Quotes 5-day view Delayed Nasdaq
05/16/2022
05/17/2022
05/18/2022
05/19/2022
05/20/2022
Date
1.7(c)
1.54(c)
1.5(c)
1.53(c)
1.53(c)
Last
72 065
147 800
123 960
155 531
125 895
Volume
0.00% -9.41% -2.60% +2.00% 0.00% Change
Estimated financial data (e) (USD)
Sales 2022
0,57 M - -
Net income 2022
-20,0 M - -
Net cash position 2022
58,0 M - -
P/E ratio 2022
-1,49x
Yield 2022
-
Sales 2023
13,7 M - -
Net income 2023
-47,3 M - -
Net cash position 2023
9,00 M - -
P/E ratio 2023
-1,04x
Yield 2023
-
Capitalization
47,3 M 47,3 M -
EV / Sales 2022
-18,7x
EV / Sales 2023
2,80x
Nbr of Employees
114
Free-Float
69,6%
Sera Prognostics, Inc. is a women’s health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers...
Ratings of Sera Prognostics, Inc.
All news about SERA PROGNOSTICS, INC.
05/19 Sera Prognostics, Inc. Announces Publication of Data Demonstrating Improved Performance.. CI
05/19 Sera prognostics announces publication of data demonstrating improved performance of it.. PR
05/18 Sera prognostics presents data demonstrating the health and economic benefit of pretrm®.. PR
05/16 Berenberg Bank Adjusts Sera Prognostics' Price Target to $12 From $13, Maintains Buy Ra.. MT
05/10 Earnings Flash (SERA) SERA PROGNOSTICS Reports Q1 Revenue $38,000 MT
05/10 SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and.. AQ
05/10 Sera Prognostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2.. CI
05/10 Sera prognostics reports first quarter 2022 financial results PR
05/05 Sera prognostics and newborn foundation partner to reduce risks associated with preterm.. PR
05/02 Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 202.. PR
04/27 Berenberg Bank Initiates Coverage on Sera Prognostics With Buy Rating, $13 Price Target MT
04/12 SERA PROGNOSTICS, INC. : Change in Directors or Principal Officers, Financial Statements a..AQ
04/12 Sera Prognostics, Inc Appoints Jane F. Barlow as Director to the Board to Serve as Clas.. CI
03/30 Oppenheimer Adjusts Sera Prognostics Price Target to $17 From $19, Maintains Outperform.. MT
03/30 Citigroup Downgrades Sera Prognostics to Neutral From Buy, Adjusts Price Target to $4 F.. MT
News in other languages on SERA PROGNOSTICS, INC.
Analyst Recommendations on SERA PROGNOSTICS, INC.
Chart SERA PROGNOSTICS, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1,53 $
Average target price
10,33 $
Spread / Average Target
575%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
